financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Hold Opinion On Shares Of Fortive
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Hold Opinion On Shares Of Fortive
Oct 31, 2025 12:45 AM

03:25 AM EDT, 10/31/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We lift our 12-month target to $55 (from $50), valuing shares at 20x our 2026 EPS outlook of $2.75 (raised from $2.65; 2025 EPS view updated to $2.64 from $3.00). FTV reported Q3 results with sales growth of 1.9% Y/Y in core sales, as IOS delivered 2.2% growth and AHS achieved 1.1%, both below historical levels amid persistent market headwinds. Despite top-line challenges, the company demonstrated strong margin resilience with adjusted EBITDA margins expanding 220 bps Y/Y to 30.1%, supported by IOS margins of 34.6% (+130 bps) and AHS margins of 28.1% (+120 bps). We view the margin expansion as reflecting benefits from the simplified operating structure and ongoing productivity initiatives across both segments. FTV executed an aggressive $1.0B share repurchase program during the quarter, representing approximately 6% of diluted shares outstanding, while raising 2025 EPS guidance to $2.63-$2.67, from $2.50-$2.60.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Raises Opinion On Health Care To Marketweight From Underweight
Research Alert: CFRA Raises Opinion On Health Care To Marketweight From Underweight
Oct 8, 2025
01:40 PM EDT, 10/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: After Pfizer Inc. (PFE 26 ****) and the U.S. government struck the first Most Favored Nation (MFN) drug pricing deal to lower drug prices in the U.S., we see policy...
Research Alert: CFRA Lowers Opinion On Lucid Group Inc. Shares To Strong Sell From Sell
Research Alert: CFRA Lowers Opinion On Lucid Group Inc. Shares To Strong Sell From Sell
Oct 7, 2025
08:20 AM EDT, 10/07/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our 12-month target of $10. We lower our adjusted EPS estimates to -$11.15 from -$10.50 for 2025 and to -$11.50 from -$11.00 for 2026. LCID posted Q3 vehicle...
Research Alert: CFRA Keeps Sell Opinion On Shares Of Mccormick & Company, Incorporated
Research Alert: CFRA Keeps Sell Opinion On Shares Of Mccormick & Company, Incorporated
Oct 7, 2025
02:30 PM EDT, 10/07/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our 12-month target by $1 to $59, about 19x our FY 26 (Nov.) EPS estimate of $3.12 (down from $3.14; FY 25 raised to $3.03 from $2.97). This...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Constellation Brands Inc.
Research Alert: CFRA Maintains Buy Opinion On Shares Of Constellation Brands Inc.
Oct 7, 2025
11:50 AM EDT, 10/07/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our 12-month target by $10 to $175, based on a 2027 P/E of 13.7x, a steep but justified discount to STZ's 10-year average forward P/E of 21.6x. We...
Copyright 2023-2026 - www.financetom.com All Rights Reserved